NASDAQ · Biotechnology

Yarrow Bioscience, Inc. (YARW) Stock

$20.10 +1.16% NASDAQ: YARW Healthcare

Valuation

MetricValue
Price$20.10
Market Cap$187.02M
P/E Ratio-0.87
P/B Ratio0.79
P/S Ratio391.86
EPS (TTM)$-1550.00
52-Week High$46.95
52-Week Low$16.04
Dividend Yield7.93%

Financials & Margins

MetricValue
ROE-70.23%
ROA-79.26%
ROCE-90.33%
Gross Margin98.68%
Operating Margin-3000.00%
Net Margin-2600.00%
Debt/Equity0.00
Current Ratio20.86

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$0$0$1.0M$1.0M
Operating Profit$-39.0M$-34.0M$-29.0M$-44.0M$-30.0M
Net Profit$-73.0M$-23.0M$-28.0M$-40.0M$-26.0M
EPS$-1282.44$-566.98$-138.48$-46.77$-30.96
Op Margin-4179.5%-7189.7%-6900.5%-8710.0%-5219.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$67.0M$41.0M$98.0M$67.0M$30.0M
Total Liabilities$18.0M$10.0M$9.0M$15.0M$2.0M
Cash$42.0M$31.0M$31.0M$20.0M$24.0M
Borrowings$0$0$0$0$0

Latest News

Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves’ Disease and Thyroid Eye Disease Business Wire · Jul 27, 2026 VYNE Approves 1-for-50 Reverse Stock Split MT Newswires · Jul 21, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-56.0M$-29.0M$-25.0M$-34.0M$-33.0M
Investing Cash Flow$1.0M$16.0M$-57.0M$23.0M$37.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-16.0M$-12.0M$0$-11.0M$4.0M
Free Cash Flow$-56.0M$-29.0M$-25.0M$-34.0M$-33.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-8.81
FCF Yield-8.97%
Quick Ratio15.26
Interest Coverage0.00
Return 1Y179.45%
Return 3Y-76.08%
Return 5Y-97.71%

Ownership

Insiders Held4.27%
Institutions Held9.43%
Institutions Float Held9.85%
Institutional HolderSharesReport Date
Nantahala Capital Management, LLC40,0002026-03-31
Lynx1 Capital Management Lp32,5742026-03-31
Shay Capital LLC32,2052026-03-31
Anson Funds Management LP24,8622026-03-31
Adar1 Capital Management, LLC 21,2782026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AIMAIM ImmunoTech Inc. $0.18 -1.75% -0.05 $7.04M 0.00%
BCLIBrainstorm Cell Therapeutics Inc. $0.98 +6.52% -1.04 $10.81M 0.00%
ENSCEnsysce Biosciences, Inc. $0.46 +6.66% -0.16 $7.04M 0.00%
KALAKALA BIO, Inc. $0.30 -17.61% -0.01 $5.74M 0.00%
KTTAPasithea Therapeutics Corp. $0.44 -0.56% -0.19 $14.73M 0.00%

About Yarrow Bioscience, Inc.

Yarrow Bioscience, Inc. is headquartered in US.

Yarrow Bioscience, Inc. (YARW) stock trades at $20.10 with a market capitalization of $187.02M. The stock is valued at a price-to-earnings (P/E) ratio of -0.87, price-to-book of 0.79, price-to-sales of 391.86. Over the past 52 weeks the stock has ranged between $16.04 and $46.95, and currently trades 57.2% below its 52-week high. It pays a dividend yielding 7.93%.

On profitability, Yarrow Bioscience, Inc. generates a return on equity (ROE) of -70.23%, return on capital employed of -90.33%, an operating margin of -3000.00%, a net profit margin of -2600.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1170.74 +0.10% JNJ Johnson & Johnson $259.53 +1.19% ABBV AbbVie Inc. $275.22 +1.03% MRK Merck & Company, Inc. Common Stock (new) $145.01 +1.85% UNH UnitedHealth Group Incorporated Common Stock (DE) $374.45 +0.94% NVS Novartis AG $143.67 +0.39% AZN AstraZeneca PLC $159.80 +0.64% TMO Thermo Fisher Scientific Inc $656.26 +0.66% AMGN Amgen Inc. $410.76 +0.82% GILD Gilead Sciences, Inc. $149.60 +1.70% ABT Abbott Laboratories $99.59 +1.12% NVO Novo Nordisk A/S $38.39 +0.54%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides